Results
p37 following infection with 10 2 B. burgdorferi, further suggesting that these antigens are expressed in vivo (Figures 4A and 4B) . Immunoglobulin (Ig) G to both P35 Identification of p35 and p37 Previous differential screening of a lambda ZAP II B.
and P37 could be detected as early as 14 days after infection and peaked at 30 days. By 60-90 days followburgdorferi expression library with immune serum from mice infected with B. burgdorferi for 90 days and also ing infection, these antibody responses had diminished and practically disappeared by 180 days. In contrast, with hyperimmune serum from mice immunized with heat-killed spirochetes revealed 14 phage clones that IgG to B. burgdorferi whole-cell lysates continued to increase with persistent infection ( Figure 4C ). Since spirepresented five B. burgdorferi genes (or members of gene families) that expressed antigens selectively reacrochetes are normally transmitted by tick bite, we measured the antibody response to P35 and P37 in mice tive with immune sera (Suk et al., 1995) . Two of these five groups of clones now also showed strong reactivity infected with B. burgdorferi following tick bite. At 14 days following tick-borne infection, antibodies to P35 with antibodies in the immune sera of 30-day infected mice. The genes encoding these two immunogenic antiand P37 were detectable by immunoblot ( Figure 4D ). gens were sequenced and designated p35 and p37. p35 and p37 had open reading frames of 927 and 996
Patients with Lyme Disease Develop nucleotides, respectively (Figures 1A and 1B) . Ϫ35 and P35 and P37 Antibodies Ϫ10 regions as well as ribosome binding sites were
We assessed the human IgM and IgG responses to P35 identified upstream of the respective open reading and P37 using a reference panel of 43 sera from patients frames. The deduced amino acid sequence of P37 rewith well-documented Lyme disease that were carefully vealed a phenylalanine-X-Y-cysteine motif and a hyselected by the Centers for Disease Control (Fort Collins, drophobic leader sequence, consistent with a lipoproColorado). Twenty-seven of the individuals were culturetein. Pulsed-field gel electrophoresis demonstrated that positive for B. burgdorferi, including 25 patients with both these genes are encoded on different plasmids: erythema migrans (skin) and 2 individuals with meningip35 and p37 are on plasmids with the mobility of a 42 tis (cerebrospinal fluid). Overall, 31 of the 43 (72%) paand 16 kb linear DNA, respectively ( Figure 1C ). tients had IgG or IgM to P35 and/or P37 by ELISA, including 24 of 33 patients with early-stage disease and p35 and p37 Are Expressed In Vivo 7 of 10 patients with late-stage disease (Table 1) . ThirtyBecause the differential immunologic screening sugfour of these 43 patients (79%) tested positive for Lyme gested that these antigens are selectively synthesized disease in immunoblots using B. burgdorferi whole-cell in vivo, we performed further molecular studies. RNA lysates as the substrate: the 9 patients who tested negafrom cultured B. burgdorferi was probed with p35 and tive in both assays uniformly had early disease that was p37 in Northern blot analyses. p35 and p37 RNA were effectively treated with antibiotics, and were culturenot detected, while ospA RNA (control) was identified positive from biopsy specimens of the erythema migrans ( Figure 2A ). In addition, ospA, but not p35 or p37, could lesion. IgM to P35 or P37 and IgG to P35 and P37 were be identified in RNase protection assay using RNA from evident in 11, 8, 23 , and 25 of these 43 individuals, cultured spirochetes ( Figure 2C ) and RT-PCR using RNA respectively. As shown in Figure 5 , pooled sera (1:100 from cultured B. burgdorferi showed a band consistent dilution) from a group of 5 individuals with well-docuwith ospA, but not p35 or p37 ( Figure 2B ). To ensure mented Lyme disease had strong IgG and IgM rethat the B. burgdorferi used in the assays contained p35 sponses to glutathione transferase (GT)-P35 (IgG: optior p37 DNA, Southern dot blot analyses were performed: cal density [OD] 1.43 Ϯ 0.24; IgM: OD 0.72 Ϯ 0.15) and as expected, DNA for ospA, p35, and p37 could be GT-P37 (IgG: OD 1.13 Ϯ 0.31; IgM: OD 0.39 Ϯ 0.08) and detected ( Figure 2D ). little reactivity to GT (IgG: OD 0.12 ϩ 0.04; IgM: 0.17 Ϯ We then used a variety of strategies to show that p35 0.04). The mean OD values for the 43 patient sera were and p37 were selectively expressed in vivo. Total RNA as follows: GT-P35 (IgG 0.46 Ϯ 0.12 and IgM 0.38 Ϯ was harvested and subject to RT-PCR. In the first few 0.14), GT-P37 (IgG 0.48 Ϯ 0.10 and IgM 0.36 Ϯ 0.09), days of infection, when spirochetes are localized to the and GT-P37 (IgG 0.11 Ϯ 0.04 and IgM 0.25 Ϯ 0.14). site of inoculation, p35 and p37 mRNA could not be Representative ELISA results using sera from selected detected in the skin (at the place of spirochete injection), patients are presented in Figure 5 . Sera from 4 healthy whereas flagellin mRNA (control) was readily amplified individuals, 5 patients with a history of syphilis and a ( Figures 3A and 3B ). As expected, p35, p37, or flagellin reactive VDRL, and 5 patients with systemic lupus erymRNA could not be identified at distant skin sites or the thematosis or rheumatoid arthritis did not have detectspleen ( Figure 3E ) at these early time points because able antibodies to P35 and P37. spirochetes had not yet disseminated from the inoculation site and could not be cultured from spleen or skin. At 7 and 14 days, when spirochetes had migrated from P35 and P37 Elicit Protective Immunity against Experimental B. burgdorferi Infection the site of inoculation, p35 and p37 mRNA became detectable at the initial site of infection (Figures 3C and Because P35 and P37 are synthesized in the early stages of mammalian infection, we sought to determine 3D). In addition, p35 and p37 mRNA could be amplified by RT-PCR from distant skin and spleen that had been whether the immune response to P35 and/or P37 could induce protective immunity in mice (Table 2) . Vaccinainfected for 7 or 14 days ( Figures 3F, 3G, and 3H ).
Mice developed a strong humoral response to p35 and tion with both P35 and P37 was protective against a plays in the evolution of Lyme disease. For example, while OspA is an abundant antigen on cultured spirochallenge dose of 10 4 spirochetes compared to GT-vacchetes and on B. burgdorferi within flat ticks, OspA is cinated mice ( 2 , p Յ 0.01). Active immunization with down-regulated when ticks engorge (de Silva et al., P35 alone provided partial protection against 10 4 spiro-1996). The extent to which ospA is expressed during chetes. Passive transfer of both P35 and P37 hyperimmammalian infection needs to be explored further, but mune sera provided full protection against 10 2 ( 2 , p Յ several studies suggest that OspA is not abundant dur-0.01), but not 10 4 , spirochetes compared to GT-immuing infection. When OspA-immune mice are challenged nized mice. Moreover, P35 and P37 hyperimmune sera with host-adapted spirochetes, they develop dissemiwere also able to provide immunity when administered nated infection and disease, suggesting that spiroto mice that had been infected with 10 2 spirochetes for chetes are not vulnerable to OspA immunity once 24 hr compared to GT-immunized mice ( 2 , p Յ 0.01). adapted to the host . Moreover, In all cases when mice were infected, the severity of OspA antibodies are ephemeral during early human arthritis was similar, regardless of treatment group, sugLyme disease, and ospA mRNA is difficult to detect in gesting that once infection occurred, P35 or P37 immuthe initial period of murine infection (Schutzer et al., nity did not influence evolution of ensuing disease.
1994; Kalish et al., 1995; Montgomery et al., 1996) . Alternatively, OspA antibodies in the later stages of murine Discussion and human infection (particularly in patients with antibiotic-resistant chronic arthritis), as well as the identificaThese studies characterize p35 and p37, B. burgdorferi tion of OspA-specific T cells in individuals with Lyme genes that appear to be expressed in the early stages arthritis, imply that at some point during infection ospA of mammalian infection. Because B. burgdorferi can alis expressed (Yssel et al., 1991; Fikrig et al., 1992 ; Kalish ter its antigenic structure, it is important to understand et al., 1993). The degree to which and the reasons why the extent to which variation occurs and the role that the B. burgdorferi surface protein synthesis changes during the spirochetal life cycle are not known. immune response to selectively synthesized proteins P35 and P37 were first identified by differentially
The kinetics of both P35 and P37 antibody responses during persistent B. burgdorferi infection of mice are screening a B. burgdorferi expression library with immune sera from B. burgdorferi-infected mice and anistriking, with peak antibody responses within 30 days of infection, followed by decline. This suggests that these mals hyperimmunized with heat-killed spirochetes. This technique previously identified p21, an ospE homolog antigens are priming an immune response only during the early stages of infection. It is notable that identical that is induced in vivo (Suk et al., 1995) . To identify p21, the library was probed with immune sera from mice antibody kinetics occur when the passive protective activity of immune serum is titrated in persistently infected infected with B. burgdorferi for 180 days. In contrast, when p35 and p37 were found, the library was screened mice. In contrast, IgG to B. burgdorferi whole-cell lysates increases from 30 to 90 days, and antibodies to with sera obtained from mice infected for 30 and 90 days, in an effort to facilitate the identification of genes an antigen that is likely to be constitutively expressed (flagellin) continue to be present in high titer. The parallel that are induced in the early stages of infection. The detection of P35 and P37 with immune sera from mice kinetics of P35 and P37 antibody with protective antibody kinetics suggests that P35 and P37 are among during early but not later stages of infection may explain why p35 and p37 were not uncovered in the initial the antigens likely to be responsible for the protective activity in sera of actively infected mice. screening strategy (using 180-day immune sera) that revealed p21. The selective induction of p35 and p37 in Since p35 and p37 expression occurs early in infection, we sought to determine the role of P35 and P37 the mammalian host and the lack of in vitro expression were confirmed by the detection of p35 and p37 mRNA in antibodies in immunity. Immune sera from B. burgdorferi-infected mice have the capacity to both protect mice B. burgdorferi-infected murine tissue but not in cultured spirochetes, and the presence of P35 and P37 antibodfrom infection, eliminate infection up to 4 days after inoculation, and induce arthritis resolution in actively ies in the serum of infected mice and patients with Lyme disease.
infected mice, whereas hyperimmune sera to heat-killed 
B. burgdorferi-whole-cell lysate based immunoblots (IgM and IgG) were assessed by the Centers for Disease Control according to the banding criteria established by Dressler et al. (1993) .
spirochetes is only protective but does not influence the early stages of murine and human Lyme borreliosis also suggests that P35 and P37 antibodies may be useful infection or disease after inoculation . This unique capacity of immune serum to clear markers of infection. Current serologic assays, including ELISA and immunoblot, that detect exposure to B. burg-B. burgdorferi during early infection, suggests the response to in vivo induced antigens is responsible for dorferi use whole-cell lysates of cultured spirochete as the substrate and therefore cannot detect antibody rethis effect. Indeed, antibodies to OspA (with profound protective capabilities in vaccine studies) are abundant sponses to proteins expressed in vivo (Stanek et al., 1987; Magnarelli, 1989; Dressler et al., 1993) . This is in the sera of mice hyperimmunized with heat-killed spirochetes but cannot eliminate the pathogen once infeclikely to result in an incomplete assessment of the immune response to B. burgdorferi. Studies analyzing the tion is established (Fikrig et al., 1993) . Sera from B. burgdorferi-infected mice recognized flagellin, P39, and temporal development of the human and murine response to B. burgdorferi using whole-cell lysate-based OspC on immunoblot, suggesting that antibodies to these proteins may elicit the protective, postinfectious, systems have indicated that, in general, antibodies to flagellin, P39, and OspC appear in the early stages of or disease-modulating effect of immune serum. However, when antisera against these specific proteins were disease and that antibodies to numerous spirochetal antigens develop as the infection continues (Dressler et administered to B. burgdorferi-infected mice, no effects were noted . Our current studies al., 1993; Barthold et al., 1995; Barthold et al., 1996; Magnarelli et al., 1996) . While antibodies to these proshow that P35 and P37 antisera have the capacity to protect mice from infection, when administered both teins certainly are elicited during infection (suggesting that many antigens are expressed both in vitro and in prior to and 24 hr after B. burgdorferi challenge. Therefore, P35 and P37 antibodies provides a basis for undervivo), the response to in vivo induced gene products is not discernible using standard assays. Our data suggest standing the protective capacity of sera from B. burgdorferi-infected mice.
that the evolution of the humoral response is more complex that previously considered. Indeed, it is likely that The data also indicate that p35 and p37 are expressed several days after the spirochetes are introduced into several genes are induced or inhibited at various stages of infection and that current detection methods are unthe skin. p35 and p37 mRNA could not be detected in biopsy specimens from the site of experimental inoculaable to identify antibodies to these antigens because they lack the "in vivo" antigen. This paradigm may extion for up to 48 hr but could be identified in skin and tissue specimens at 7 and 14 days. During experimental tend beyond Lyme disease and apply to other microbes that result in persistent infection. murine Lyme borreliosis, spirochetes disseminate from the initial skin lesion at 3-5 days and then spread hema-
Experimental Procedures
togenously to visceral organs and other cutaneous sites . p35 and p37 expression tempo- The prominent humoral response to P35 and P37 in transferase fusion protein) or GT-P37 (recombinant P37 prepared as a GT fusion protein) in CFA and boosting the animal twice over a period of 1 month; in each case the P35 or P37 antibodies were present at a titer of 1: 25,000 by immunoblot). GT antisera (control) were prepared in an identical fashion.
Library Screening
A lambda ZAP II genomic expression library of B. burgdorferi N40 was used (Lam et al., 1994) . The phage plaques were probed with immune sera from 30 day-infected mice and hyperimmune sera from B. burgdorferi-hyperimmunized mice. Sera (1: 100 dilution in phosphate-buffered saline [PBS]) were used as the primary antibody. Secondary antibodies were goat anti-mouse immunoglobulin conjugated to alkaline phosphatase and were detected following incubation with nitroblue tetrazolium (NBT) and 5-bromo-4-chloro-3-indolyl-phosphate (BCIP). Plaques that reacted uniquely with immune sera but not hyperimmune sera were subjected to secondary and tertiary screening. pBluescript plasmids that contained genes encoding reactive antigens were excised using the R408 helper phage (Lam et al., 1994) . The nucleotide sequences of the genes encoded on the plasmid inserts were then determined using the Circumvent Thermal Cycle Dideoxy DNA sequencing kit (New England Biolabs) and designated p35 and p37 respectively, based on the estimated size of the gene products.
Pulsed-Field Gel Electrophoresis
Pulsed-field gel electrophoresis was performed with B. burgdorferi DNA (Lam et al., 1994) . DNA plugs containing approximately 10 5 B. burgdorferi N40 were loaded onto a 0.8% agarose gel and run in Tris-borate-EDTA buffer (0.025 M Tris, 0.5 mM EDTA, 0.025 M boric acid), using the Chef-DRII system (Bio-Rad Laboratories, Richmond, CA). The gel was run at 14ЊC for 18 hr at 198 V, with ramped pulse times from 1 to 30 s. Southern blotting was carried out with p35 and p37 probes labeled with (␣-32 P) dCTP, using the Prime-It random primer kit (Stratagene, La Jolla, CA).
Northern Blot Analysis
Total RNA was isolated from cultured B. burgdorferi by acid guanidinium thiocyanate phenol-chloroform extraction. Ten micrograms of the recovered RNA was electrophoresed in a 1% formaldehydeagarose gel and blotted onto a Hybond-N-membrane. The blotted membrane was prehybridized in 50% formamide for 1 hr at 42ЊC, Figure 5 . ELISA (IgM and IgG) Using Recombinant GT-P35 or GTand then hybridized, using the same conditions, with probes for p35, P37 as the Substrate and Sera from Representative Patients with p37, or ospA overnight. Random-primed 32 P-labeled DNA inserts Lyme Disease encoding p35 (920 bp), p37 (960 bp) and ospA (800 bp) were used as probes. The membranes were washed in 0.1 ϫ SSC and 0.1% The serologic responses of 8 individuals, 5 with erythema migrans SDS at 55ЊC prior to exposure and development of film. (the second and fourth patients were culture-positive), 3 with arthritis, and 1 with meningitis, are shown. Positive control sera (pos. control) are pooled from 5 patients with well-documented Lyme RNase Protection Assays The extracted RNA from cultured B. burgdorferi was hybridized with disease, from our clinic at Yale, with IgG or IgM antibodies to B. burgdorferi whole-cell lysates. Negative control sera are pooled a 32 P-labeled cRNA probe made from subcloned DNA containing selected B. burgdorferi genes, p35 (AccI, 190 bp), p37 (XmnI, 390 from 3 healthy individuals. bp) and ospA (PstI, 180 bp). The DNAs that spanned regions of p37 (nucleotides 606-996), p35 (nucleotides 737-927), and ospA (nucleotides 642-822) were subcloned into pBluescript. The antiMice sense and sense 32 P-UTP-labeled cRNA probes were transcribed Three-week-old female C3H/HeNCr (C3H) mice were obtained from using T7 and T3 polymerase. Template DNA was removed using the Frederick Cancer Research Center (Frederick, MD). Mice were RNase-free DNase. The RPA II ribonuclease protection assay kit housed in filter-frame cages and euthanized with carbon dioxide.
(Ambion, Austin, TX) was utilized for hybridization, RNase digestion and electrophoretic separation. The gel was exposed to film for 24 Antibodies hr. Sense probes produced no hybridization. Sera were obtained from mice infected (immune sera) or hyperimmunized (hyperimmune sera) with B. burgdorferi. For infection, mice were given with an intradermal inoculation of 10 2 B. burgdorferi N40. PCR Conditions for PCR amplification of B. burgdorferi DNA were 30 Sera were obtained from the animals at 7, 14, 28, 42, 60, 90, 180 , and 270 days. All the mice had verified infection based on culture cycles with a denaturing, annealing and extension temperature of 94ЊC for 1 min, 55ЊC for 1 min, and 72ЊC for 2 min. 5Ј and 3Ј primers of spleen, urinary bladder, and/or skin. For hyperimmunization, groups of 5 mice were injected with 10 7 heat-killed spirochetes in for PCR were 5Ј-GCGGTGAAAGTGGT GAATTGG-3Ј and 5Ј-CTTTA GCAAAGTTGTCAAGGCGTG-3Ј for p35; 5-GACAA CAACAGAAGTG complete Freund's adjuvant (CFA) and given booster injections at 2 and 4 weeks with the same number of B. burgdorferi in incomplete GTCGCAC-3Ј and 5Ј-TAGCATCGGAATGAGCTGTGCC-3Ј for p37; 5Ј-TCTGACGATCTAGGTCAAACCACA-3Ј and 5Ј-CCCTCTAATTTG Freund's adjuvant (IFA). Mice hyperimmunized with heat-killed B. burgdorferi were culture-negative at the time of sacrifice. P35 or GTGCCATTTG-3Ј for ospA; and 5Ј-CAATCAGGTAACGGC-3Ј and 5Ј-TCTATTTTGGAAAGC-3Ј for flagellin. For RT-PCR, total RNA was P37 antisera were prepared by hyperimmunizing a rabbit with 50 g of either GT-P35 (recombinant P35 prepared as a glutathione isolated from the spleens, or the skin (5 mm section) of mice infected In the active immunization studies, P35-and/or P37-or GT (control)-vaccinated mice were challenged with inocula of 10 2 or 10 4 B. burgdorferi 14 days after the final boost and then killed at 14 days. In the passive immunization studies, mice were administered rabbit P35-and/or P37 hyperimmune sera or anti-GT hyperimmune serum (control). The antisera were given to the animals 1 day prior to or 24 hr after (24 hr post) challenge with B burgdorferi. Blood, urinary bladder, spleen, and skin punches were cultured in BSK II medium for 2 weeks and examined by dark-field microscopy for spirochetes. The tibiotarsi and heart were examined microscopically for inflammation. Mice from which B. burgdorferi were isolated from at least one tissue specimen and/or had evidence of disease were considered to be infected. were then applied to the coated plates and incubated for 1 hr at primers for either p35, p37, or ospA were then added. The reactions room temperature. Plates were then washed three times with PBST. were carried out at 70ЊC for 15 min. "Upstream" primers and MgCl 2 Goat anti-human or goat anti-mouse IgM and IgG, each diluted solution were then added as suggested by the manufacturer. PCR 1:2000 and linked to alkaline phosphatase, were then added to each was carried out for 30 cycles of 94ЊC for 1 min, 53ЊC for 1 min, and well. Plates were incubated at room temperature for 1 hr and washed 72ЊC for 2 min.
three times with PBST, and then 200 l of freshly prepared p-nitrophenol phosphate, (1 mg/ml in glycine buffer, pH 10.5) was added to each well and monitored at 405 nm. The reaction was Protein Purification stopped with 3 M NaOH. Recombinant P35 and P37 were expressed as fusion proteins with GT. The p35 and p37 genes were cloned into pMX, a modified pGEX-2T vector (Sears et al., 1991) . To facilitate subcloning, the p35 and Immunoblots p37 genes were amplified using 5Ј primers with an additional XhoI Recombinant GT-P35 or GT-P37 were resolved in 12% minigels (for p35) and BamHI (for p37) restriction enzyme digestion site and by SDS PAGE and transferred to nitrocellulose membranes. One a 3Ј primer with a supplementary HindIII (for p35) or XhoI (for p37) microgram of recombinant antigen was loaded on each lane. The site. Plasmid DNA obtained from initial phage colonies was used nitrocellulose strips containing recombinant protein were then as the template for p35 and p37. Amplified gene products were probed with antiserum (diluted 1:100). The secondary antibody was digested with either XhoI and BamHI or HindIII and XhoI and cloned alkaline phosphatase conjugated goat anti-mouse or anti-human into the corresponding sites in the pMX plasmid. The ligation mixture immunoglobulin. Color development was performed using NBT and was then used to transform Escherichia coli DH5␣, and colonies BCIP. containing the recombinant plasmid were isolated on Luria broth supplemented with ampicillin.
Immunization Studies Recombinant fusion protein production was induced by growing Groups of 5 mice were hyperimmunized subcutaneously with 10 g the bacteria to logarithmic phase and adding 1 mM isopropyl-1-of recombinant GT-P35 and/or GT-P37 in CFA and boosted at 14 thio-␤-galactoside (IPTG) for 3 hr. The E. coli were then placed in and 28 days with the same amount of antigen in IFA, according to PBS with 1% Triton and subjected to sonication. The cell supernapublished protocols (Fikrig et al., 1990) . Control mice were hyperimtant and pellet were separated by centrifugation at 1000 ϫ g for 8 munized with recombinant GT in an identical fashion. Fourteen days min. Recombinant fusion proteins present in the supernatant were following the last boost, sera from the hyperimmunized animals was then purified by passage over a glutathione column (Fikrig et al., used to probe recombinant P35 or P37 (prepared without the GT 1990). The fusion proteins, GT-P35 or GT-P37, were eluted from the fusion partner) to determine the presence and titer of specific anticolumn using a solution containing excess glutathione and quantibody. Hyperimmunized mice were challenged 14 days after the last fied. Recombinant GT (control antigen) was prepared in an identical boost with intradermal inoculations of 10 2 or 10 4 spirochetes. In fashion. Purified P35 and P37, without the GT fusion partner, were passive immunization studies, mice were administered 0.2 ml of GTalso obtained, for the pMX vector contains a thrombin cleavage P35 and/or GT-P37 hyperimmune sera. Control mice were given GT site immediately following the GT protein. After the supernatant hyperimmune sera. Passively immunized mice were challenged with containing the recombinant P35 or P37 fusion protein was passed 10 2 or 10 4 B. burgdorferi either 24 hr prior to or 24 hr after passive onto the glutathione column, a solution containing thrombin was immunization. In all the studies, mice were killed 14 days after chaladded to the column to cleave the recombinant proteins from the lenge. At necropsy, blood, spleen, urinary bladder and skin punches glutathione transferase.
